Breo Ellipta 200 mcg

BREO ELLIPTA 200 MCG is an inhalation powder containing fluticasone furoate, used for managing respiratory conditions. This medication is designed to help control symptoms and improve breathing.

BREO ELLIPTA 200 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways, which can help alleviate symptoms such as wheezing, shortness of breath, and coughing. This medication is not intended for immediate relief of acute symptoms but rather for long-term management.

Common effects of BREO ELLIPTA 200 MCG may include throat irritation, hoarseness, and oral thrush. Some users might experience headaches or nasal congestion. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

BREO ELLIPTA 200 MCG should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of oral thrush. This medication should not be used to treat acute symptoms or status asthmaticus. Always follow the prescribed dosage and administration instructions.

BREO ELLIPTA 200 MCG may interact with other medications, including certain antifungal and antiviral drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol and other respiratory medications should be used with caution.